• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

10
4
3
3
1

COUNTRY

3
1
1

CATEGORIES

  • 32
  • 14
  • 7
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

17
27
36
55

PUBLISHED

3
6
18
55

PRODUCT TYPE

35
12
5
3

Search "Acne Vulgaris" returned 55 results.

PRODUCT TITLE

Acne Vulgaris Global Clinical Trials Review, H2, 2013

Acne Vulgaris Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2013" provides data on the Acne Vulgaris clinical trial scenario....

September 2013
FROM
Acne Vulgaris - Pipeline Review, H1 2013 Acne Vulgaris - Pipeline Review, H1 2013 - Product Thumbnail Image

Acne Vulgaris - Pipeline Review, H1 2013

Acne Vulgaris – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM

Acne Vulgaris - Pipeline Review, H2 2013

Acne Vulgaris - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM
Acne Vulgaris - Pipeline Review, H2 2012 Acne Vulgaris - Pipeline Review, H2 2012 - Product Thumbnail Image

Acne Vulgaris - Pipeline Review, H2 2012

Acne Vulgaris – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H2 2012', provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides...

August 2012
FROM

Acne Vulgaris Global Clinical Trials Review, H2, 2012

Acne Vulgaris Global Clinical Trials Review, H2, 2012 Summary Our clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2012" provides data on the Acne Vulgaris clinical trial scenario....

September 2012
FROM

Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials

GBI Research, the leading business intelligence provider, has released its latest research ‘Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success...

January 2012
FROM

Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers

Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers Summary GBI Research’s report ‘Clinical Trial Recruitment in Dermatology...

October 2011
FROM

Acne Vulgaris Global Clinical Trials Review, H2, 2011

Acne Vulgaris Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2011" provides data on the Acne Vulgaris clinical...

November 2011
FROM
Acne Vulgaris - Pipeline Review, H1 2012 Acne Vulgaris - Pipeline Review, H1 2012 - Product Thumbnail Image

Acne Vulgaris - Pipeline Review, H1 2012

Acne Vulgaris – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H1 2012', provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides...

February 2012
FROM

Acne Vulgaris Global Clinical Trials Review, Q2, 2011

Acne Vulgaris Global Clinical Trials Review, Q2, 2011 Summary GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, Q2, 2011" provides data on the Acne Vulgaris clinical...

June 2011
FROM

Acne Vulgaris-Pipeline Insights

This “ Acne Vulgaris-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for...

February 2015
FROM

Acne Vulgaris - Pipeline Review, Q1 2011

Acne Vulgaris - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, Q1 2011', provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides...

February 2011
FROM

Acne Vulgaris - Pipeline Review, H2 2011

Acne Vulgaris - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H2 2011', provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides...

September 2011
FROM

Acne Vulgaris - Pipeline Review, Q4 2010

Acne Vulgaris - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Acne Vulgaris Pipeline Review, Q4 2010”, provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides...

December 2010
FROM

Acne Vulgaris Global Clinical Trials Review, Q4, 2010

Acne Vulgaris Global Clinical Trials Review, Q4, 2010 Summary Our clinical trial report, “Acne Vulgari Global Clinical Trials Review, Q4, 2010" provides data on the Acne Vulgari clinical trial scenario....

December 2010
FROM

Acne Vulgaris - Pipeline Review, H2 2014

Acne Vulgaris - Pipeline Review, H2 2014 Summary This, ‘Acne Vulgaris - Pipeline Review, H2 2014’, provides an overview of the Acne Vulgaris’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM

Acne Vulgaris - Pipeline Review, H1 2014

Acne Vulgaris - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acne Vulgaris - Pipeline Review, H1 2014’, provides an overview of the Acne Vulgaris’s therapeutic pipeline. This report...

March 2014
FROM
Acne Vulgaris-API Insights Acne Vulgaris-API Insights - Product Thumbnail Image

Acne Vulgaris-API Insights

Summary Acne Vulgaris-API Insights, 2015 report provides Acne Vulgaris drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea...

April 2015
FROM
Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - Product Thumbnail Image

Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Acne Vulgaris....

February 2015
FROM
Acne Vulgaris- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment Acne Vulgaris- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment - Product Thumbnail Image

Acne Vulgaris- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Acne Vulgaris- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

September 2014
FROM
Loading Indicator

Our Clients

Amneal Pharmaceuticals LLC. Amgen Inc. LEO Laboratories Ltd. Pfizer, Inc. Roche Diagnostics Ltd. Merck & Co., Inc. Sanofi S.A.